Skip to content
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Immunology

Your Journey with Nijmegen Breakage Syndrome

At a Glance

Nijmegen Breakage Syndrome is caused by changes in both copies of the NBN gene, which helps repair DNA. It can lead to small head size, immune problems, growth and developmental differences, and increased cancer risk, making coordinated specialist care and regular surveillance important.

Hearing the words “Nijmegen Breakage Syndrome” (NBS) often marks the end of one difficult journey and the beginning of another. For many families, this diagnosis arrives after a long “diagnostic odyssey”—a period of searching for answers to unexplained symptoms like a small head size (microcephaly) or frequent infections [1][2].

It is completely normal to feel a wave of conflicting emotions. You may feel a sense of relief that the search for a name is over, but that relief is often quickly followed by shock, confusion, or a deep sense of worry about what this means for your child’s future [3][4]. You are not alone in these feelings; parents of children with rare genetic conditions often describe this moment as a major life pivot that requires both time and specialized support to process [5][6].

What is Nijmegen Breakage Syndrome?

Nijmegen Breakage Syndrome is an exceptionally rare genetic condition that affects how the body maintains its “instruction manual,” the DNA. In plain language, it is a DNA-repair disorder [7].

Every day, the DNA in our cells naturally suffers small breaks. Most people have a protein called nibrin (produced by the NBN gene) that acts like a specialized repair crew, rushing to fix these breaks before they cause problems [8][9]. In children with NBS, the nibrin protein is impaired or deficient because of changes (variants) in both copies of the NBN gene [10][11].

Without this repair crew, the DNA remains “unstable.” This instability is the underlying cause of the various health challenges seen in NBS, as the body’s cells cannot grow, develop, or protect themselves as they should [12][13].

Why Is It So Rare?

NBS is one of the rarest conditions in the world. It is most frequently found in people of Slavic descent (including those with heritage from Poland, Ukraine, Belarus, Russia, and the Czech Republic) [14][15].

This is because of a “founder effect”—a specific genetic change that occurred in a common ancestor hundreds of generations ago and has been passed down through these populations [14]. In some parts of Eastern Europe, the prevalence is estimated at about 2 to 3 per million people, though it can be higher in specific regions [15][16]. Outside of these populations, the condition is even more rare. However, NBS can occur in children of any ancestry, and ancestry alone should never determine whether a child receives testing or specialist care.

Hallmark Features of NBS

While every child is unique, NBS typically presents with a group of “hallmark” features that doctors use to recognize the condition [10]:

  • Microcephaly: A head size that is smaller than average, usually noticed at birth and becoming more prominent as the child grows [10][17].
  • Characteristic Facial Features: Many children share a characteristic facial appearance, which may include a prominent nose, receding forehead, and large eyes [17][18].
  • Immune System Challenges: A combined immunodeficiency, meaning the body has trouble making both the cells and the antibodies needed to fight off germs [19][20]. This often leads to frequent respiratory or sinus infections [10].
  • Growth and Development: Children frequently experience slower-than-average physical growth and varying degrees of developmental delay, learning differences, or intellectual disability [10][17].

Navigating the Uncertainty

One of the hardest parts of an NBS diagnosis is the uncertainty regarding the long-term “trajectory” or path of the disease. Because the DNA is unstable, children with NBS have a significantly higher risk of developing certain types of cancer, particularly lymphoma (a cancer of the immune system) [21][22].

Research shows that while the risk is high—with a large international registry study estimating a cumulative cancer incidence of about 40% by age 10 and nearly 78% by age 20—these are broad statistics [21][11]. It is important to remember that these figures reflect a specific historical cohort and cannot predict exactly what will happen for your specific child. What we do know is that early and consistent surveillance (regular check-ups and testing) is the best tool we have for managing this risk [19][23].

The Importance of Coordinated Care

Because NBS affects so many different parts of the body—the immune system, the brain, and the blood—it cannot be managed by a single doctor. Your child needs a coordinated care center or a multidisciplinary team [6]. This team usually includes:

  1. Immunologists to manage infection risks and immune health [19].
  2. Oncologists to create a personalized cancer screening plan [24].
  3. Geneticists to help your family understand the inheritance and provide counseling [23].
  4. Neurologists and Developmental Specialists to support your child’s growth and learning [25].

A critical rule for this entire team is the avoidance of nonessential ionizing radiation. Because your child’s cells cannot repair DNA damage effectively, standard X-rays, CT scans, and radiation therapy can be much more harmful to them than to other children [10][18]. However, you should never delay life-saving emergency imaging. Your specialized care team will help you navigate alternative imaging options, such as MRI or ultrasound, whenever possible.

Living with this diagnosis is a marathon, not a sprint. Focusing on building a team you trust and finding ways to connect with other NBS families can help turn the initial shock of diagnosis into a structured, proactive plan for your child’s care [26][27].

Common questions in this guide

How is Nijmegen Breakage Syndrome confirmed?
Genetic testing can confirm Nijmegen Breakage Syndrome by identifying disease-causing changes in both copies of the NBN gene. The genetics team can also explain whether the changes were inherited from each parent and what the results mean for the family.
What are the main signs of Nijmegen Breakage Syndrome?
NBS commonly includes microcephaly, or a smaller-than-average head size, characteristic facial features, frequent respiratory or sinus infections, and slower physical growth. Children may also have developmental delay, learning differences, or intellectual disability, but features and severity vary.
Does Nijmegen Breakage Syndrome increase a child’s cancer risk?
Yes. Children with NBS have a much higher risk of certain cancers, particularly lymphoma. A large historical registry estimated that the cumulative risk was about 40% by age 10 and nearly 78% by age 20, but those group estimates cannot predict an individual child’s outcome, so regular surveillance is important.
What kind of specialists should care for a child with NBS?
Care is usually coordinated through a multidisciplinary center with experience in NBS. The team may include an immunologist, oncologist, geneticist, neurologist, and developmental specialist, with each clinician addressing a different part of the child’s health.
Why should children with NBS avoid unnecessary X-rays and CT scans?
Impaired DNA repair can make nonessential ionizing radiation, including radiation from standard X-rays and CT scans, more harmful for a child with NBS. The care team may choose MRI or ultrasound when appropriate, but emergency imaging should not be delayed when it is needed to save a life.
Is Nijmegen Breakage Syndrome limited to children of Slavic ancestry?
No. NBS is reported more often in people with Slavic or Eastern European heritage because of a founder effect, but it can occur in children of any ancestry. Ancestry alone should never decide whether a child receives genetic testing or specialist care.
How are immune problems monitored in Nijmegen Breakage Syndrome?
An immunologist assesses the child’s immune status and monitors it over time, while the care team watches for recurrent infections. The exact follow-up plan is individualized and should be coordinated with the child’s specialists.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has genetic testing confirmed pathogenic variants in both copies of the NBN gene, and do you know if these variants were inherited from each of us?
  2. 2.Can you refer us to a multidisciplinary center that has specific experience managing Nijmegen Breakage Syndrome?
  3. 3.Which specialists will be on our child's core care team (e.g., immunology, oncology, genetics, neurology)?
  4. 4.What is our child's current immune status, and how will we monitor it over time?
  5. 5.How do we ensure that every doctor or radiology technician our child sees knows to avoid nonessential ionizing radiation?
  6. 6.What is the specific cancer screening and surveillance plan tailored for our child's age and diagnosis?
  7. 7.What local or national support organizations or parent networks can you recommend for NBS families?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    "Crying in the Wilderness"-The Use of Web-Based Support in Telomere Biology Disorders: Thematic Analysis.

    Pearce EE, Majid A, Brown T, et al.

    JMIR formative research 2024; (8()):e64343 doi:10.2196/64343.

    PMID: 39680438
  2. 2

    Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.

    Krabbenborg L, Vissers LE, Schieving J, et al.

    Journal of genetic counseling 2016; (25(6)):1207-1214 doi:10.1007/s10897-016-9958-5.

    PMID: 27098417
  3. 3

    Parental Experiences of Receiving a Rare Genetic Disease Diagnosis for Their Child on Diagnosis Day.

    Bullock I, Malone KF, Turnwald A

    American journal of medical genetics. Part A 2026; (200(1)):67-76 doi:10.1002/ajmg.a.64223.

    PMID: 40820471
  4. 4

    Rare and resilient: Longer-term experiences of families after genetic evaluation in the neonatal intensive care unit.

    Abouhala S, Del Rosario MC, Holm IA, Wojcik MH

    Genetics in medicine open 2026; (4()):103490 doi:10.1016/j.gimo.2025.103490.

    PMID: 41657716
  5. 5

    Genome sequencing among children with medical complexity: What constitutes value from parents' perspective?

    Lee W, Luca S, Costain G, et al.

    Journal of genetic counseling 2022; (31(2)):523-533 doi:10.1002/jgc4.1522.

    PMID: 34674352
  6. 6

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830
  7. 7

    Functional Role of NBS1 in Radiation Damage Response and Translesion DNA Synthesis.

    Saito Y, Komatsu K

    Biomolecules 2015; (5(3)):1990-2002 doi:10.3390/biom5031990.

    PMID: 26308066
  8. 8

    Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex.

    Otahalova B, Volkova Z, Soukupova J, et al.

    International journal of molecular sciences 2023; (24(6)) doi:10.3390/ijms24065612.

    PMID: 36982687
  9. 9

    Mutation Spectra of the MRN (MRE11, RAD50, NBS1/NBN) Break Sensor in Cancer Cells.

    McPherson MT, Holub AS, Husbands AY, Petreaca RC

    Cancers 2020; (12(12)) doi:10.3390/cancers12123794.

    PMID: 33339169
  10. 10

    Nijmegen breakage syndrome: case report and review of literature.

    Hasbaoui BE, Elyajouri A, Abilkassem R, Agadr A

    The Pan African medical journal 2020; (35()):85 doi:10.11604/pamj.2020.35.85.14746.

    PMID: 32537088
  11. 11

    Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application.

    Salewsky B, Hildebrand G, Rothe S, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2016; (24(1)):117-24 doi:10.1038/mt.2015.144.

    PMID: 26265251
  12. 12

    Effect of irradiation on DNA synthesis, NBN gene expression and chromosomal stability in cells with NBN mutations.

    Nowak J, Świątek-Kościelna B, Kałużna EM, et al.

    Archives of medical science : AMS 2017; (13(2)):283-292 doi:10.5114/aoms.2017.65452.

    PMID: 28261280
  13. 13

    Evidence for a pre-malignant cell line in a skin biopsy from a patient with Nijmegen breakage syndrome.

    Habib R, Neitzel H, Ernst A, et al.

    Molecular cytogenetics 2018; (11()):17 doi:10.1186/s13039-018-0364-6.

    PMID: 29445421
  14. 14

    The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?

    Seemanova E, Varon R, Vejvalka J, et al.

    PloS one 2016; (11(12)):e0167984 doi:10.1371/journal.pone.0167984.

    PMID: 27936167
  15. 15

    Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c.657_661del5.

    Sharapova SO, Pashchenko OE, Bondarenko AV, et al.

    Frontiers in immunology 2020; (11()):602482 doi:10.3389/fimmu.2020.602482.

    PMID: 33488600
  16. 16

    Nijmegen breakage syndrome: 25-year experience of diagnosis and treatment in Ukraine.

    Boyarchuk O, Kostyuchenko L, Akopyan H, et al.

    Frontiers in immunology 2024; (15()):1428724 doi:10.3389/fimmu.2024.1428724.

    PMID: 39007137
  17. 17

    A case of premature ovarian insufficiency in Nijmegen breakage syndrome patient and review of literature. From gene mutation to clinical management.

    Szeliga A, Zysnarska A, Szklarska Z, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2019; (35(11)):999-1002 doi:10.1080/09513590.2019.1626366.

    PMID: 31187634
  18. 18

    Radiosensitivity in a newborn with microcephalia: A case report of Nijmegen breakage syndrome.

    Cakmak Genc G, Yilmaz B, Karakas Celik S, et al.

    Birth defects research 2024; (116(5)):e2346 doi:10.1002/bdr2.2346.

    PMID: 38761025
  19. 19

    Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.

    Wolska-Kuśnierz B, Gregorek H, Chrzanowska K, et al.

    Journal of clinical immunology 2015; (35(6)):538-49 doi:10.1007/s10875-015-0186-9.

    PMID: 26271390
  20. 20

    T Lymphocytes in Patients With Nijmegen Breakage Syndrome Demonstrate Features of Exhaustion and Senescence in Flow Cytometric Evaluation of Maturation Pathway.

    Piatosa B, Wolska-Kuśnierz B, Tkaczyk K, et al.

    Frontiers in immunology 2020; (11()):1319 doi:10.3389/fimmu.2020.01319.

    PMID: 32695108
  21. 21

    Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.

    Wolska-Kusnierz B, Pastorczak A, Fendler W, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2021; (27(2)):575-584 doi:10.1158/1078-0432.CCR-20-2574.

    PMID: 33082212
  22. 22

    Generation of NBS1 knockout in Chinese hamster cells revealed ATR role for radiation and etoposide induced DNA damage in absence of NBS1 proteins.

    Badakul G, Maeda J, Kato TA

    Frontiers in oncology 2026; (16()):1776137 doi:10.3389/fonc.2026.1776137.

    PMID: 41959910
  23. 23

    Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.

    Nakano Y, Kuiper RP, Nichols KE, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2024; (30(22)):5009-5020 doi:10.1158/1078-0432.CCR-24-1098.

    PMID: 39264246
  24. 24

    Caregiver quality of life and burden in rare genetic diseases in South Korea.

    Choi S, Kim JH, Kim GH, et al.

    Medicine 2026; (105(11)):e48006 doi:10.1097/MD.0000000000048006.

    PMID: 41824885
  25. 25

    Impaired p53-Mediated DNA Damage Response Contributes to Microcephaly in Nijmegen Breakage Syndrome Patient-Derived Cerebral Organoids.

    Martins S, Erichsen L, Datsi A, et al.

    Cells 2022; (11(5)) doi:10.3390/cells11050802.

    PMID: 35269426
  26. 26

    Social Media Use Among Parents and Caregivers of Children With Rare Genetic Diseases: Scoping Review.

    Davis C, Bogaert L, Powell J, Low K

    Journal of medical Internet research 2025; (27()):e77087 doi:10.2196/77087.

    PMID: 41313807
  27. 27

    Hearing parents' voices: A priority-setting workshop to inform a suite of psychological resources for parents of children with rare genetic epilepsies.

    Nevin SM, Wakefield CE, Dadich A, et al.

    PEC innovation 2022; (1()):100014 doi:10.1016/j.pecinn.2021.100014.

    PMID: 37364015

This page provides general information about Nijmegen Breakage Syndrome for families and does not replace medical advice. Your child’s genetics, immunology, oncology, and other specialists should tailor testing, surveillance, imaging, and care to your child.

Get notified when new evidence is published on Nijmegen breakage syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.